Frequently Asked Questions
How does TrueCold support pharmaceutical cold chain compliance?
TrueCold provides native support for 21 CFR Part 11, EU Annex 11, Global GDP, and GAMP 5, automatically generating audit-ready records and release decisions. This lets pharmaceutical quality teams demonstrate regulatory compliance without manual reconciliation.
Can TrueCold handle ultra-cold and Cell & Gene Therapy (CGT) logistics?
Yes. TrueCold is specialized for high-value APIs, Cell & Gene Therapy (CGT), and ultra-cold logistics where zero-loss handling is critical. It tracks each shipment's stability budget in real time so temperature-sensitive biologics are protected end to end.
Why does Mean Kinetic Temperature (MKT) matter for biologics?
Mean Kinetic Temperature (MKT) is a single calculated temperature that reflects the cumulative thermal stress a product accumulates over time, which is what actually degrades sensitive biologics. TrueCold computes MKT continuously to flag at-risk shipments before stability limits are breached.
How does TrueCold reduce QA bottlenecks for pharma release?
TrueCold uses real-time stability data and regulatory thresholds to automatically trigger 'Released' or 'Quarantined' actions in your ERP. By automating these decisions, it can reduce manual QA release workloads by up to 90%.

